Dissecting the pathophysiologic role of endogenous lectins: Glycan-binding proteins with cytokine-like activity?

Cytokine and Growth Factor Reviews

Volumn 18, Issue 1-2, 2007, Pages 57-71

  Toscano, Marta A ^a   Ilarregui, Juan M ^a   Bianco, Germán A ^a   Campagna, Leonardo ^a   Croci, Diego O ^a   Salatino, Mariana ^a   Rabinovich, Gabriel A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Chemokines; Collectins; Cytokines; Galectins; Glycosylation; Immunoregulation; Lectins

Indexed keywords

COLLECTIN; ECALECTIN; GALECTIN 1; GALECTIN 12; GALECTIN 2; GALECTIN 3; GALECTIN 4; GALECTIN 7; GALECTIN 8; GLYCAN BINDING PROTEIN; LECTIN; MANNOSE BINDING LECTIN; PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CHRONIC INFLAMMATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; INNATE IMMUNITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR IMMUNITY;

ANIMALS; AUTOIMMUNITY; CHRONIC DISEASE; COLLECTINS; CYTOKINES; GALECTIN 1; HUMANS; INFECTION; INFLAMMATION; NEOPLASMS; ORGAN TRANSPLANTATION; POLYSACCHARIDES;

EID: 33947161979     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2007.01.006     Document Type: Article

References (144)

1. Ohtsubo K., and Marth J.D. Glycosylation in cellular mechanisms of health and disease. Cell 126 (2006) 855-867
2. Lowe J.B. Glycosylation, immunity, and autoimmunity. Cell 104 (2001) 809-812
3. Dube D.H., and Bertozzi C.R. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat Rev Drug Discov 4 (2005) 477-488
4. Daniels M.A., Hogquist K.A., and Jameson S.C. Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat Immunol 3 (2002) 903-910
5. Gabius H.J. Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. Crit Rev Immunol 26 (2006) 43-79
6. Sharon N., and Lis H. History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 14 (2004) 53-62
7. Gabius H.-J. Special issue: animal lectins. Biochim Biophys Acta 1572 (2002) 165-434
8. Barondes S.H. In: Liener I.E., Sharon N., and Goldstein I.J. (Eds). The lectins (1986), Academic Press, Orlando, FL 467-491
9. Kilpatrick D.C. Animal lectins: a historical introduction and overview. Biochim Biophys Acta 1572 (2002) 187-197
10. Teichberg V.I., Silman I., Beitsch D.D., and Resheff G. A β-d-galactoside binding protein from electric organ tissue of Electrophorus electricus. Proc Natl Acad Sci USA 72 (1975) 1383-1387
11. Rabinovich G.A., Baum L.G., Tinari N., Paganelli R., Natoli C., Liu F.T., et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?. Trends Immunol 23 (2002) 313-320
12. Cooper D.N. Galectinomics: finding themes in complexity. Biochim Biophys Acta 1572 (2002) 209-231
13. Leffler H., Carlsson S., Hedlund M., Qian Y., and Poirier F. Introduction to galectins. Glycoconj J 19 (2004) 433-440
14. Liu F.T., and Rabinovich G.A. Galectins as modulators of tumour progression. Nat Rev Cancer 5 (2005) 29-41
15. Brewer C.F. Binding and cross-linking properties of galectins. Biochim Biophys Acta 1572 (2002) 255-262
16. Ilarregui J.M., Bianco G.A., Toscano M.A., and Rabinovich G.A. The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders. Ann Rheum Dis 64 (2005) 96-103
17. Rabinovich G.A., Iglesias M.M., Modesti N.M., Castagna L.F., Wolfenstein-Todel C., Riera C.M., et al. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. J Immunol 160 (1998) 4831-4840
18. Zuniga E., Rabinovich G.A., Iglesias M.M., and Gruppi A. Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis. J Leukoc Biol 70 (2001) 73-79
19. Blaser C., Kaufmann M., Muller C., Zimmermann C., Wells V., Mallucci L., et al. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol 28 (1998) 2311-2319
20. Garin M.I., Chu C.C., Golshayan D., Cernuda-Morollon E., Wait R., and Lechler R.I. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood (2006) [Epub ahead of print]
21. Sugimoto N., Oida T., Hirota K., Nakamura K., Nomura T., Uchiyama T., et al. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int Immunol 18 (2006) 1197-1209
22. Rabinovich G.A., Rubinstein N., and Toscano M.A. Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta 1572 (2002) 274-284
23. Hirabayashi J., Hashidate T., Arata Y., Nishi N., Nakamura T., Hirashima M., et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572 (2002) 232-254
24. Baum L.G., Blackall D.P., Arias-Magallano S., Nanigian D., Uh S.Y., Browne J.M., et al. Amelioration of graft versus host disease by galectin-1. Clin Immunol 109 (2003) 295-307
25. Offner H., Celnik B., Bringman T.S., Casentini-Borocz D., Nedwin G.E., and Vandenbark A.A. Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol 28 (1990) 177-184
26. Rabinovich G.A., Daly G., Dreja H., Tailor H., Riera C.M., Hirabayashi J., et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190 (1999) 385-398
27. Rabinovich G.A., Sotomayor C.E., Riera C.M., Bianco I., and Correa S.G. Evidence of a role for galectin-1 in acute inflammation. Eur J Immunol 30 (2000) 1331-1339
28. Santucci L., Fiorucci S., Cammilleri F., Servillo G., Federici B., and Morelli A. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology 31 (2000) 399-406
29. Santucci L., Fiorucci S., Rubinstein N., Mencarelli A., Palazzetti B., Federici B., et al. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124 (2003) 1381-1394
30. Sacchettini J.C., Baum L.G., and Brewer C.F. Multivalent protein-carbohydrate interactions: a new paradigm for supermolecular assembly and signal transduction. Biochemistry 40 (2001) 3009-3015
31. Levi G., Tarrab-Hazdai R., and Teichberg V.I. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur J Immunol 13 (1983) 500-507
32. Toscano M.A., Commodaro A.G., Ilarregui J.M., Bianco G.A., Liberman A., Serra H.M., et al. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J Immunol 176 (2006) 6323-6332
33. Perone M.J., Bertera S., Tawadrous Z.S., Shufesky W.J., Piganelli J.D., Baum L.G., et al. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J Immunol 177 (2006) 5278-5289
34. Romero M.D., Muino J.C., Bianco G.A., Ferrero M., Juarez C.P., Luna J.D., et al. Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis. Invest Ophthalmol Vis Sci 47 (2006) 1550-1556
35. Perillo N.L., Uittenbogaart C.H., Nguyen J.T., and Baum L.G. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med 185 (1997) 1851-1858
36. Perillo N.L., Pace K.E., Seilhamer J.J., and Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature 378 (1995) 736-739
37. Rabinovich G.A., Modesti N.M., Castagna L.F., Landa C., Riera C.M., and Sotomayor C.E. Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a β-galactoside-binding lectin. J Biochem 122 (1997) 365-373
38. Rabinovich G.A., Ramhorst R.E., Rubinstein N., Corigliano A., Daroqui M.C., Kier-Joffe E.B., et al. Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms. Cell Death Differ 9 (2002) 661-670
39. Matarrese P., Tinari A., Mormone E., Bianco G.A., Toscano M.A., Ascione B., et al. Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission. J Biol Chem 280 (2005) 6969-6985
40. Hahn H.P., Pang M., He J., Hernandez J.D., Yang R.Y., Li L.Y., et al. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ 11 (2004) 1277-1286
41. Pace K.E., Hahn H.P., Pang M., Nguyen J.T., and Baum L.G. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J Immunol 165 (2000) 2331-2334
42. Dias-Baruffi M., Zhu H., Cho M., Karmakar S., McEver R.P., and Cummings R.D. Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J Biol Chem 278 (2003) 41282-41293
43. Walzel H., Blach M., Hirabayashi J., Kasai K.I., and Brock J. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 10 (2000) 131-140
44. Pace K.E., Lee C., Stewart P.L., and Baum L.G. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 163 (1999) 3801-3811
45. Nguyen J.T., Evans D.P., Galvan M., Pace K.E., Leitenberg D., Bui T.N., et al. CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans. J Immunol 167 (2001) 5697-5707
46. Galvan M., Tsuboi S., Fukuda M., and Baum L.G. Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J Biol Chem 275 (2000) 16730-16737
47. Amano M., Galvan M., He J., and Baum L.G. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. J Biol Chem 278 (2003) 7469-7475
48. Allione A., Wells V., Forni G., Mallucci L., and Novelli F. Beta-galactoside-binding protein (β-GBP) alters the cell cycle, up-regulates expression of the α- and β-chains of the IFN-γ receptor, and triggers IFN-γ-mediated apoptosis of activated human T lymphocytes. J Immunol 161 (1998) 2114-2119
49. Rappl G., Abken H., Muche J.M., Sterry W., Tilgen W., Andre S., et al. CD4+CD7- leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death. Leukemia 16 (2002) 840-845
50. Roberts A.A., Amano M., Felten C., Galvan M., Sulur G., Pinter-Brown L., et al. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation. Mod Pathol 16 (2003) 543-551
51. Cabrera P.V., Amano M., Mitoma J., Chan J., Said J., Fukuda M., et al. Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death. Blood 108 (2006) 2399-2406
52. Rabinovich G.A., Alonso C.R., Sotomayor C.E., Durand S., Bocco J.L., and Riera C.M. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2. Cell Death Differ 7 (2000) 747-753
53. Ion G., Fajka-Boja R., Toth G.K., Caron M., and Monostori E. Role of p56lck and ZAP70-mediated tyrosine phosphorylation in galectin-1-induced cell death. Cell Death Differ 12 (2005) 1145-1147
54. Ion G., Fajka-Boja R., Kovacs F., Szebeni G., Gombos I., Czibula A., et al. Acid sphingomyelinase mediated release of ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1. Cell Signal 18 (2006) 1887-1896
55. Endharti A.T., Zhou Y.W., Nakashima I., and Suzuki H. Galectin-1 supports survival of naive T cells without promoting cell proliferation. Eur J Immunol 35 (2005) 86-97
56. Barrionuevo P., Beigier-Bompadre M., Ilarregui J.M., Toscano M.A., Bianco G.A., Isturiz M.A., et al. A novel function for galectin-1 at the crossroad of innate and adaptive immunity: Galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J Immunol 178 (2007) 436-445
57. Thijssen V.L., Postel R., Brandwijk R.J., Dings R.P., Nesmelova I., Satijn S., et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 103 (2006) 15975-15980
58. Vespa G.N., Lewis L.A., Kozak K.R., Moran M., Nguyen J.T., Baum L.G., et al. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J Immunol 162 (1999) 799-806
59. Chung C.D., Patel V.P., Moran M., Lewis L.A., and Miceli M.C. Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol 165 (2000) 3722-3729
60. Rabinovich G.A., Ariel A., Hershkoviz R., Hirabayashi J., Kasai K.I., and Lider O. Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1. Immunology 97 (1999) 100-106
61. van der Leij J., van den Berg A., Blokzijl T., Harms G., van Goor H., Zwiers P., et al. Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response. J Pathol 204 (2004) 511-518
62. Fulcher J.A., Hashimi S.T., Levroney E.L., Pang M., Gurney K.B., Baum L.G., et al. Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix. J Immunol 177 (2006) 216-226
63. Levroney E.L., Aguilar H.C., Fulcher J.A., Kohatsu L., Pace K.E., Pang M., et al. Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines. J Immunol 175 (2005) 413-420
64. Correa S.G., Sotomayor C.E., Aoki M.P., Maldonado C.A., and Rabinovich G.A. Opposite effects of galectin-1 on alternative metabolic pathways of l-arginine in resident, inflammatory, and activated macrophages. Glycobiology 13 (2003) 119-128
65. Zuniga E., Gruppi A., Hirabayashi J., Kasai K.I., and Rabinovich G.A. Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival. Infect Immun 69 (2001) 6804-6812
66. O'Connell J., Bennett M.W., O'Sullivan G.C., Collins J.K., and Shanahan F. The Fas counterattack: cancer as a site of immune privilege. Immunol Today 20 (1999) 46-52
67. Camby I., Le Mercier M., Lefranc F., and Kiss R. Galectin-1: a small protein with major functions. Glycobiology 16 (2006) 137-157
68. Rubinstein N., Alvarez M., Zwirner N.W., Toscano M.A., Ilarregui J.M., Bravo A., et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege. Cancer Cell 5 (2004) 241-251
69. Le Q.T., Shi G., Cao H., Nelson D.W., Wang Y., Chen E.Y., et al. Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23 (2005) 8932-8941
70. Sturm A., Lensch M., Andre S., Kaltner H., Wiedenmann B., Rosewicz S., et al. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 173 (2004) 3825-3837
71. Ozaki K., Inoue K., Sato H., Iida A., Ohnishi Y., Sekine A., et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 429 (2004) 72-75
72. Yang R.Y., Hsu D.K., and Liu F.T. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 93 (1996) 6737-6742
73. Akahani S., Nangia-Makker P., Inohara H., Kim H.R., and Raz A. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57 (1997) 5272-5276
74. Fukumori T., Takenaka Y., Yoshii T., Kim H.R., Hogan V., Inohara H., et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 63 (2003) 8302-8311
75. Stillman B.N., Hsu D.K., Pang M., Brewer C.F., Johnson P., Liu F.T., et al. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176 (2006) 778-789
76. Demetriou M., Granovsky M., Quaggin S., and Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409 (2001) 733-739
77. Hsu D.K., Yang R.Y., Pan Z., Yu L., Salomon D.R., Fung-Leung W.P., et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 156 (2000) 1073-1083
78. Colnot C., Ripoche M.A., Milon G., Montagutelli X., Crocker P.R., and Poirier F. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology 94 (1998) 290-296
79. Karlsson A., Follin P., Leffler H., and Dahlgren C. Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood 91 (1998) 3430-3438
80. Almkvist J., Dahlgren C., Leffler H., and Karlsson A. Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1. J Immunol 168 (2002) 4034-4041
81. Kuwabara I., and Liu F.T. Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 156 (1996) 3939-3944
82. Sato S., Ouellet N., Pelletier I., Simard M., Rancourt A., and Bergeron M.G. Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. J Immunol 168 (2002) 1813-1822
83. Nieminen J., St-Pierre C., and Sato S. Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses. J Leukoc Biol 78 (2005) 1127-1135
84. Sano H., Hsu D.K., Apgar J.R., Yu L., Sharma B.B., Kuwabara I., et al. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 112 (2003) 389-397
85. Sano H., Hsu D.K., Yu L., Apgar J.R., Kuwabara I., Yamanaka T., et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 165 (2000) 2156-2164
86. Fernandez G.C., Ilarregui J.M., Rubel C.J., Toscano M.A., Gomez S.A., Beigier Bompadre M., et al. Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways. Glycobiology 15 (2005) 519-527
87. Cortegano I., del Pozo V., Cardaba B., de Andres B., Gallardo S., del Amo A., et al. Galectin-3 down-regulates IL-5 gene expression on different cell types. J Immunol 161 (1998) 385-389
88. Lopez E., del Pozo V., Miguel T., Sastre B., Seoane C., Civantos E., et al. Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model. J Immunol 176 (2006) 1943-1950
89. Zuberi R.I., Hsu D.K., Kalayci O., Chen H.Y., Sheldon H.K., Yu L., et al. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol 165 (2004) 2045-2053
90. Hokama A., Mizoguchi E., Sugimoto K., Shimomura Y., Tanaka Y., Yoshida M., et al. Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20 (2004) 681-693
91. Wada J., Ota K., Kumar A., Wallner E.I., and Kanwar Y.S. Developmental regulation, expression, and apoptotic potential of galectin-9, a β-galactoside binding lectin. J Clin Invest 99 (1997) 2452-2461
92. Kashio Y., Nakamura K., Abedin M.J., Seki M., Nishi N., Yoshida N., et al. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 170 (2003) 3631-3636
93. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6 (2005) 1245-1252
94. Dai S.Y., Nakagawa R., Itoh A., Murakami H., Kashio Y., Abe H., et al. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol 175 (2005) 2974-2981
95. Matsumoto R., Hirashima M., Kita H., and Gleich G.J. Biological activities of ecalectin: a novel eosinophil-activating factor. J Immunol 168 (2002) 1961-1967
96. Bernerd F., Sarasin A., and Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci USA 96 (1999) 11329-11334
97. Kuwabara I., Kuwabara Y., Yang R.Y., Schuler M., Green D.R., Zuraw B.L., et al. Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem 277 (2002) 3487-3497
98. Hadari Y.R., Arbel-Goren R., Levy Y., Amsterdam A., Alon R., Zakut R., et al. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 113 (2000) 2385-2397
99. M. Glycobiology 13 (2003) 755-763
100. Yang R.Y., Hsu D.K., Yu L., Ni J., and Liu F.T. Cell cycle regulation by galectin-12, a new member of the galectin superfamily. J Biol Chem 276 (2001) 20252-20260
101. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 1 (2001) 135-145
102. Holmskov U., Thiel S., and Jensenius J.C. Collectins and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 21 (2003) 547-578
103. van de Wetering J.K., van Golde L.M., and Batenburg J.J. Collectins: players of the innate immune system. Eur J Biochem 271 (2004) 1229-1249
104. Stuart L.M., Henson P.M., and Vandivier R.W. Collectins: opsonins for apoptotic cells and regulators of inflammation. Curr Dir Autoimmun 9 (2006) 143-161
105. Bouwman L.H., Roep B.O., and Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol 67 (2006) 247-256
106. Wright J.R. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5 (2005) 58-68
107. Matsushita M., and Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 176 (1992) 1497-1502
108. Dommett R.M., Klein N., and Turner M.W. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68 (2006) 193-209
109. Super M., Thiel S., Lu J., Levinsky R.J., and Turner M.W. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 2 (1989) 1236-1239
110. Miller M.E., Seals J., Kaye R., and Levitsky L.C. A familial, plasma-associated defect of phagocytosis: a new cause of recurrent bacterial infections. Lancet 292 (1968) 60-63
111. Turner M.W. The role of mannose-binding lectin in health and disease. Mol Immunol 40 (2003) 423-429
112. Eisen D.P., and Minchinton R.M. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37 (2003) 1496-1505
113. Fraser D.A., Bohlson S.S., Jasinskiene N., Rawal N., Palmarini G., Ruiz S., et al. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol 80 (2006) 107-116
114. Nadesalingam J., Dodds A.W., Reid K.B., and Palaniyar N. Mannose-binding lectin recognizes peptidoglycan via the N-acetyl glucosamine moiety, and inhibits ligand-induced proinflammatory effect and promotes chemokine production by macrophages. J Immunol 175 (2005) 1785-1794
115. Sprong T., Jack D.L., Klein N.J., Turner M.W., van der Ley P., Steeghs L., et al. Mannose binding lectin enhances IL-1β and IL-10 induction by non-lipopolysaccharide (LPS) components of Neisseria meningitidis. Cytokine 28 (2004) 59-66
116. Chaka W., Verheul A.F., Vaishnav V.V., Cherniak R., Scharringa J., Verhoef J., et al. Induction of TNF-α in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol 159 (1997) 2979-2985
117. Ghezzi M.C., Raponi G., Angeletti S., and Mancini C. Serum-mediated enhancement of TNF-α release by human monocytes stimulated with the yeast form of Candida albicans. J Infect Dis 178 (1998) 1743-1749
118. Santos I.K., Costa C.H., Krieger H., Feitosa M.F., Zurakowski D., Fardin B., et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun 69 (2001) 5212-5215
119. Takahashi K., Gordon J., Liu H., Sastry K.N., Epstein J.E., Motwani M., et al. Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect 4 (2002) 773-784
120. Shi L., Takahashi K., Dundee J., Shahroor-Karni S., Thiel S., Jensenius J.C., et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 199 (2004) 1379-1390
121. Jack D.L., Read R.C., Tenner A.J., Frosch M., Turner M.W., and Klein D.J. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 184 (2001) 1152-1162
122. Crouch E., and Wright J.R. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 63 (2001) 521-554
123. Sano H., and Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol Immunol 42 (2005) 279-287
124. Sano H., Sohma H., Muta T., Nomura S., Voelker D.R., and Kuroki Y. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J Immunol 163 (1999) 387-395
125. Murakami S., Iwaki D., Mitsuzawa H., Sano H., Takahashi H., Voelker D.R., et al. Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-α secretion in U937 cells and alveolar macrophages by direct interaction with Toll-like receptor 2. J Biol Chem 277 (2002) 6830-6837
126. Hickling T.P., Sim R.B., and Malhotra R. Induction of TNF-α release from human buffy coat cells by Pseudomonas aeruginosa is reduced by lung surfactant protein A. FEBS Lett 437 (1998) 65-69
127. Rosseau S., Hammerl P., Maus U., Gunther A., Seeger W., Grimminger F., et al. Surfactant protein A down-regulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes. J Immunol 163 (1999) 4495-4502
128. Sato M., Sano H., Iwaki D., Kudo K., Konishi M., Takahashi H., et al. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-α secretion are down-regulated by lung collectin surfactant protein A. J Immunol 171 (2003) 417-425
129. Reidy M.F., and Wright J.R. Surfactant protein A enhances apoptotic cell uptake and TGF-β1 release by inflammatory alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 285 (2003) 854-861
130. Song M., and Phelps D.S. Interaction of surfactant protein A with lipopolysaccharide and regulation of inflammatory cytokines in the THP-1 monocytic cell line. Infect Immun 68 (2000) 6611-6617
131. Kremlev S.G., and Phelps D.S. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol 267 (1994) 712-719
132. Chabot S., Salez L., McCormack F.X., Touqui L., and Chignard M. Surfactant protein A inhibits lipopolysaccharide-induced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation. Am J Respir Cell Mol Biol 28 (2003) 347-353
133. Gardai S.J., Xiao Y.Q., Dickinson M., Nick J.A., Voelker D.R., Greene K.E., et al. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115 (2003) 13-23
134. Borron P., McIntosh J.C., Korfhagen T.R., Whitsett J.A., Taylor J., and Wright J.R. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol 278 (2000) L840-L847
135. LeVine A.M., Kurak K.E., Bruno M.D., Stark J.M., Whitsett J.A., and Korfhagen T.R. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 19 (1998) 700-708
136. Harrod K.S., Trapnell B.C., Otake K., Korfhagen T.R., and Whitsett J.A. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am J Physiol 277 (1999) 580-588
137. Hawgood S., Brown C., Edmondson J., Stumbaugh A., Allen L., Goerke J., et al. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol 78 (2004) 8565-8572
138. Giannoni E., Sawa T., Allen L., Wiener-Kronish J., and Hawgood S. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 34 (2006) 704-710
139. LeVine A.M., Whitsett J.A., Gwozdz J.A., Richardson T.R., Fisher J.H., Burhans M.S., et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 165 (2000) 3934-3940
140. Borron P., McCormack F.X., Elhalwagi B.M., Chroneos Z.C., Lewis J.F., Zhu S., et al. Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am J Physiol 275 (1998) 679-686
141. Borron P., Veldhuizen R.A., Lewis J.F., Possmayer F., Caveney A., Inchley K., et al. Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. Am J Respir Cell Mol Biol 15 (1996) 115-121
142. Scanlon S.T., Milovanova T., Kierstein S., Cao Y., Atochina E.N., Tomer Y., et al. Surfactant protein-A inhibits Aspergillus fumigatus-induced allergic T-cell responses. Respir Res 6 (2005) 97-107
143. Madan T., Reid K.B., Singh M., Sarma P.U., and Kishore U. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus. J Immunol 174 (2005) 6943-6954
144. Blixt O., Head S., Mondala T., Scanlan C., Huflejt M.E., Alvarez R., et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 101 (2004) 17033-17038